Multi-analyte immunoassay for cancer screening and monitoring biomarkers. Supports oncology patient management and follow-up.
Manufactured by
Shenzhen, China
Rayto - China's leading provider of professional clinical application solutions in the field of in vitro diagnostics Established in 2001, we are committed to the research and development, manufacturing, sales, and service of in vitro diagnostic clinical testing devices and reagents. Our headquarters are located in Shenzhen and we have customer service 24h for global post-sale problem. The first batch of nationally recognized high-tech enterprises National biochemical analyzer and ELISA reader and washer high-tech industrialization demonstration project Shenzhen National Biological Industry Base Biomedical Electronics Industry Technology Service and Experimental Center Class A medical device enterprise in Guangdong province Shenzhen medical device industry independent innovation leading enterprise Top 500 Growth oriented Small and Medium Enterprises in Shenzhen Guangdong province coagulation and immune in vitro diagnostic Instrument and Reagent Engineering Technology Research Center Innovative small and medium-sized enterprises in Guangdong Province R D Innovation R D innovation is Rayto core competitiveness, and the company insists on investing 10% of its sales revenue in R D every year, continuously launching new products. Having multiple patented technologies and possessing 100% independent intellectual property rights for all products. The R D team take proportion over 20% of the total number of employees, bringing together professionals from multiple fields such as biomedical engineering, computer science, automation control, precision machinery, optics, biochemistry, and clinical laboratory medicine. Product Quality Rayto products cover multiple fields of in vitro diagnostic clinical testing, including immunoassay, coagulation analysis, biochemical analysis, hematology analysis, etc. The quality system complies with the most authoritative and strict German TUV ISO9001 and ISO13485 standards in the global medical device industry. Manufacturing standards, manufacturing reliance is Rayto's philosophy of quality and service. Market Sales Rayto has always focused on global market development, with products spread across more than 120 countries and regions In China, the market share of Rayto products ranks among the top, with a high reputation and market influence. Rayto has become a well-known brand of Chinese exporting instruments overseas Up to now, the global installed amount of Rayto products has exceeded 200000 units, becoming a common choice for hundreds thousands of users worldwide Customer Service Rayto insists on providing users with high-quality and humanized services A whole day customer service network, rigorously trained engineers, and ample spare parts reserves make service within reach The advanced Rayto dedicated customer service management system ensures fast response and mastery of the service process. Strict user follow-up system, timely feedback of user opinions, and ensuring service quality.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
TMD LAB CO., LTD.
South Korea · 1 relevant product
Bioantibody Biotechnology Co., Ltd.
China · 2 relevant products
Fujirebio Diagnostics,Inc.
China · 3 relevant products
Zhejiang Pushkang Biotechnology Co., Ltd.
China · 2 relevant products
Anbio Biotechnology Limited
Germany · 1 relevant product
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
YouSeq
United Kingdom · 1 relevant product
Biopsense Oy
Finland · 1 relevant product
70 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 112 closest product alternatives
TMD LAB CO., LTD. · South Korea
Immunoassay for detection of cancer-associated antigens in serum. Supports oncological screening and patient monitoring.
Bioantibody Biotechnology Co., Ltd. · China
Quantitative immunoassay for cancer-related tumor markers. Supports cancer screening, diagnosis, and treatment monitoring.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic test panel for detection of multiple tumor markers with simplified experimental workflow and reliable accuracy. The assay provides stable results suitable for cancer screening and monitoring.
Zhejiang Pushkang Biotechnology Co., Ltd. · China
Comprehensive immunochemiluminescent assay panel for cancer-related tumor markers. Compatible with automated immunomagnetic analyzer systems.
Anbio Biotechnology Limited · Germany
Comprehensive testing suite for oncology biomarkers including CEA, AFP, and CA markers. Supports cancer diagnosis, prognosis, and treatment monitoring.
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
Comprehensive kits for simultaneous detection of multiple tumor-associated markers using IHC, PCR, or FISH methodologies. These panels enable comprehensive tumor characterization and subtyping.
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
Comprehensive tumor profiling panel utilizing LBP, IHC, PCR, and FISH methods to characterize tumor biology. This integrated approach provides multi-level diagnostic information for precision oncology.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
100 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products